FDA approves AstraZeneca drugs for developmental disorders in females, males

ROCKVILLE, Md. Food and Drug Administration has approved a drug by AstraZeneca for treating developmental disorders in girls and boys.

The drug, Arimidex (anastrozole) is used for treating pubescent boys with gynecomastia—a disorder that causes boys and men to develop abnormally large breasts—and pre-pubescent girls with McCune-Albright syndrome causing progressive precocious puberty.

The FDA granted approval for the drug, in tablet form, on Dec. 5.